Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population.

Participation in a clinical trial of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population is being considered.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen